Ed Ross
Analyst · National Securities. Your line is now open
Good morning, Jody and good morning, everyone. Welcome to our third quarter 2020 earnings conference call. I hope all of you, your families, friends and co-workers are staying healthy and well. Since our first quarter earnings call when the shelter-in-place orders related to the pandemic began to weigh on our portfolio companies business operations. I have focused my prepared remarks on the state of our portfolio. As uncertainties associated with the pandemic in the economy are still with us. On this morning's call, I'm going to once again open with a status report on our portfolio. I also share you my assessment of M&A trends in the lower middle market and dealer activity levels as we move into the homestretch of 2020. Shelby will cover the third quarter financial results in our liquidity position. Once we have completed our prepared remarks, we'll be happy to take your questions. Since the pandemic hit us in the United States towards the end of the first quarter. management teams at our portfolio companies have done a great job overall of adapting their businesses to the new normal, executing plans to ensure business continuity, flexing the current demand dynamics and focusing on what they can control. Some of them are focusing on enhancing business operations, while others are taking advantage of competitive openings to accelerate growth plans. Although we are not out of the woods, yet, our portfolio companies continue to hold their own. I'm pleased to report that the overall health of the portfolio continues to improve. Our assessment of portfolio risk based on company operations and valuations has steadily abated since the first quarter, when we considered a little more than 80% of the portfolio to be in the low to medium risk range. To the second quarter when our view was that about 88% of the portfolio is in the low to medium risk range and about 65% in the low risk category. Now our view is that 93% is in the low to medium risk range with roughly 70% in the low risk category. We do still have the debt investment in Accent Food Service on nonaccrual and we wrote down the fair value of this investment by about two thirds to $5.3 million during the quarter. This portfolio company has been hard hit by the adverse effects of the pandemic. Mirage Trailers is back on accrual status. As a result, we ended the quarter with a nonaccrual balance of less than 1% of our portfolio on a fair value basis. This represents an improvement from the end of the first quarter when we had three portfolio companies on nonaccrual and one on pick nonaccrual equal to 6.7% of the portfolio on a fair value basis. In spite of the write down of Accent Foods, the NAV increased $13.4 million to $389.6 million, or $15.94 per share at the end of the third quarter, a 3.6% increase from $376.2 million, or $15.39 per share at the end of the second quarter, as improved performance and outlets at some of our portfolio companies merited appreciation in the valuations of our debt and equity investments. As you can see, our strategy of selectively investing in companies with defensive characteristics is working for us. Companies with resilient business models that can withstand economic stresses and generate strong free cash flows that operate in industries we know well and that possess positive long term outlooks. In terms of our portfolio, construction and metrics, the fair market value of our investment portfolio as of September 30, 2020, was $715.4 million equal to 99.9% of cost. We ended the quarter with 63 active portfolio companies and three companies that have sold their underlying operations. On a fair value basis the breakdown of the portfolio by investment type as of September 30, was as follows. First lien debt 18.3%, second lien debt 49.2% and subordinated debt 20.1% and equity investments 12.4%. We continue to believe our portfolio is well structured with strong equity cushions to handle severe economic stresses. Turning to our results for the quarter, we reported adjusted net investment income which we define as net investment income, excluding any capital gain incentive fee attributable the realized and unrealized gains and losses of $9.7 million or $0.40 per share, compared to $8.7 million, or $0.35 per share for the same period last year. On September 25, 2020 Fidus paid a regular quarterly dividend of $0.30 per share to stockholders of record as of September 11. On October 26, 2020, the Board of Directors declared a regular quarterly dividend of $0.30 per share. And I'm pleased to report the board also declared a supplemental cash dividend of $0.04 per share, extending Fidus record of paying special dividends to eight consecutive years. Both the regular quarterly dividend and the supplemental cash dividend will be payable on December 18, 2020 to stockholders of record as of December 4. In terms of repayments and realizations, we receive proceeds of $33.8 million and recognize $1.3 million in net realized gains. In terms of exits, we receive payment in full of $7.3 million, including prepayment penalty on first lien debt and Hoonuit, LLC. We exited our debt and equity investments in microbiology Research Associates Inc. We receive payment in full of $9 million on our subordinated debt investment and realized a gain of approximately $1.4 million on our equity investment. And we receive payment in full of $10.6 million, including a prepayment penalty on second lien debt and [indiscernible]. Subsequent to quarter end, we exited Pugh Lubricants; LLC receiving payment in full of $26.6 million, including a prepayment penalty on our second lien debt investment in realized the gain of approximately $0.5 million on the sale of our equity investment. We invested $6 million in second lien debt and $1.5 million in equity in a leading regional distributor pool equipment and supplies. The debt investment was a partial funding of a $12 million note commitment. After hitting the pause button on deal activity during the second quarter, out of an abundance caution, we began evaluating opportunities again last July while adhering to our strict underwriting disciplines. There is fertile ground for M&A in the lower middle market among companies which have not been meaningfully impacted by the pandemic. And we are seeing a fair number of high quality businesses in the market today. Based on the improving health of our portfolio in the strength of our balance sheet, we're well positioned to participate in this busy season of deal activity. This supports our view that we are staying on the path of continued improvement in the health of our portfolio. While having a fairly robust pipeline is encouraging, as we head toward the end of the year, we are nevertheless continuing to operate with an abundance of caution and managing the business for the long term, focused on generating attractive risk adjusted returns and preserving capital in the interests of our shareholders. Now I'll turn the call over to Shelby to provide some details on our financial and operating results. Shelby